Your browser doesn't support javascript.
loading
Suppression of NFAT5-mediated Inflammation and Chronic Arthritis by Novel κB-binding Inhibitors.
Han, Eun-Jin; Kim, Hyun Young; Lee, Naeun; Kim, Nam-Hoon; Yoo, Seung-Ah; Kwon, H Moo; Jue, Dae-Myung; Park, Yune-Jung; Cho, Chul-Soo; De, Tran Quang; Jeong, Dae Young; Lim, Hee-Jong; Park, Woo Kyu; Lee, Ge Hyeong; Cho, Heeyeong; Kim, Wan-Uk.
Afiliação
  • Han EJ; Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim HY; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Lee N; Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim NH; Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea.
  • Yoo SA; Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kwon HM; School of Nano-Bioscience and Chemical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
  • Jue DM; Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Park YJ; Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Cho CS; Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • De TQ; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea; Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon, Republic of Korea.
  • Jeong DY; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Lim HJ; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea; Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon, Republic of Korea.
  • Park WK; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Lee GH; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Cho H; Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea; Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon, Republic of Korea. Electronic address: hycho@krict.re.kr.
  • Kim WU; Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: wan725@catholic.ac.kr.
EBioMedicine ; 18: 261-273, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28396011
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição NFATC Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Revista: EBioMedicine Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição NFATC Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Revista: EBioMedicine Ano de publicação: 2017 Tipo de documento: Article